Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2016, Article ID 8289293, 8 pages
http://dx.doi.org/10.1155/2016/8289293
Research Article

The Effect of Poly(ADP-ribose) Polymerase-1 Gene 3′Untranslated Region Polymorphism in Colorectal Cancer Risk among Saudi Cohort

1Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia
2College of Medicine, King Saud University, Riyadh, Saudi Arabia
3Division of Gastroenterology, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia
4Division of Gastroenterology, The McGill University Health Center, Montreal General Hospital, McGill University, Montreal, QC, Canada
5Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Received 22 May 2016; Revised 28 July 2016; Accepted 31 July 2016

Academic Editor: Xiaohong Li

Copyright © 2016 Abdullah M. Alhadheq et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Jemal, M. M. Center, C. DeSantis, and E. M. Ward, “Global patterns of cancer incidence and mortality rates and trends,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 8, pp. 1893–1907, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Aljebreen, “Clinico-pathological patterns of colorectal cancer in Saudi Arabia: younger with an advanced stage presentation,” Saudi Journal of Gastroenterology, vol. 13, no. 2, pp. 84–87, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. E. M. Ibrahim, A. A. Zeeneldin, T. R. El-Khodary, A. M. Al-Gahmi, and B. M. Bin Sadiq, “Past, present and future of colorectal cancer in the Kingdom of Saudi Arabia,” Saudi Journal of Gastroenterology, vol. 14, no. 4, pp. 178–182, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Lengauer, K. W. Kinzler, and B. Vogelstein, “Genetic instabilities in human cancers,” Nature, vol. 396, no. 6712, pp. 643–649, 1998. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Dantzer, V. Schreiber, C. Niedergang et al., “Involvement of poly(ADP-ribose) polymerase in base excision repair,” Biochimie, vol. 81, no. 1-2, pp. 69–75, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. W. P. Roos, A. D. Thomas, and B. Kaina, “DNA damage and the balance between survival and death in cancer biology,” Nature Reviews Cancer, vol. 16, no. 1, pp. 20–33, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Beck, I. Robert, B. Reina-San-Martin, V. Schreiber, and F. Dantzer, “Poly(ADP-ribose) polymerases in double-strand break repair: focus on PARP1, PARP2 and PARP3,” Experimental Cell Research, vol. 329, no. 1, pp. 18–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. A. N. Weaver and E. S. Yang, “Beyond DNA repair: additional functions of PARP-1 in cancer,” Frontiers in Oncology, vol. 3, article 290, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Rouleau, A. Patel, M. J. Hendzel, S. H. Kaufmann, and G. G. Poirier, “PARP inhibition: PARP1 and beyond,” Nature Reviews Cancer, vol. 10, no. 4, pp. 293–301, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Masutani, H. Nakagama, and T. Sugimura, “Poly-ADP-ribosylation in health and disease: poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease,” Cellular and Molecular Life Sciences, vol. 62, no. 7-8, pp. 769–783, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Ossovskaya, I. C. Koo, E. P. Kaldjian, C. Alvares, and B. M. Sherman, “Upregulation of poly (ADP-Ribose) polymerase-1 (PARP1) in triple-negative breast cancer and other primary human tumor types,” Genes and Cancer, vol. 1, no. 8, pp. 812–821, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Brevik, A. D. Joshi, R. Corral et al., “Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat,” Cancer Epidemiology Biomarkers and Prevention, vol. 19, no. 12, pp. 3167–3173, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H.-T. Wang, Y. Gao, Y.-X. Zhao et al., “PARP-1 rs3219073 polymorphism may contribute to susceptibility to lung cancer,” Genetic Testing and Molecular Biomarkers, vol. 18, no. 11, pp. 736–740, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Wang, C. Qin, J. Zhu et al., “Genetic variants of XRCC1, APE1, and ADPRT genes and risk of bladder cancer,” DNA and Cell Biology, vol. 29, no. 6, pp. 303–311, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Gao, D. K. Price, W. L. Dahut, E. Reed, and W. D. Figg, “Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer,” Cancer Biology and Therapy, vol. 10, no. 1, pp. 13–18, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Li, Z. Hu, J. Lu et al., “Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck,” Cancer, vol. 110, no. 4, pp. 867–875, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Alanazi, A. A. K. Pathan, J. P. Shaik, A. A. Amri, and N. R. Parine, “The c allele of a synonymous snp (rs1805414, ala284ala) in parp1 is a risk factor for susceptibility to breast cancer in saudi patients,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 5, pp. 3051–3056, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Alanazi, A. A. K. Pathan, Z. Arifeen et al., “Association between PARP-1 V762A polymorphism and breast cancer susceptibility in Saudi population,” PLoS ONE, vol. 8, no. 12, Article ID e85541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. D. Bazzi, F. A. Nasr, M. S. Alanazi et al., “Association between FTO, MC4R, SLC30A8, and KCNQ1 gene variants and type 2 diabetes in Saudi population,” Genetics and Molecular Research, vol. 13, no. 4, pp. 10194–10203, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Alanazi, A. A. K. Pathan, S. A. Ajaj et al., “Dna repair genes XRCC1, XRCC3, XPD, AND OGG1 polymorphisms among the central region population of Saudi Arabia,” Biological Research, vol. 46, no. 2, pp. 161–167, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Bai and C. Cantó, “The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease,” Cell Metabolism, vol. 16, no. 3, pp. 290–295, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. B. C. Woodhouse and G. L. Dianov, “Poly ADP-ribose polymerase-1: an international molecule of mystery,” DNA Repair, vol. 7, no. 7, pp. 1077–1086, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Luo and W. L. Kraus, “On par with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1,” Genes & Development, vol. 26, no. 5, pp. 417–432, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. T. W. Teo, D. Landi, C. F. Taylor et al., “The role of microrna-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes,” Carcinogenesis, vol. 33, no. 3, pp. 581–586, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Zhai, S. Li, H. Li et al., “Polymorphisms in poly (ADP-ribose) polymerase-1 (PARP1) promoter and 3′ untranslated region and their association with PARP1 expression in breast cancer patients,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 6, pp. 7059–7071, 2015. View at Google Scholar · View at Scopus
  27. C. Guillot, V. Favaudon, Z. Herceg et al., “PARP inhibition and the radiosensitizing effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma models,” BMC Cancer, vol. 14, no. 1, article 603, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Cleator, W. Heller, and R. C. Coombes, “Triple-negative breast cancer: therapeutic options,” The Lancet Oncology, vol. 8, no. 3, pp. 235–244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Nosho, H. Yamamoto, M. Mikami et al., “Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis,” European Journal of Cancer, vol. 42, no. 14, pp. 2374–2381, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Sulzyc-Bielicka, P. Domagala, J. Hybiak, A. Majewicz-Broda, K. Safranow, and W. Domagala, “Colorectal cancers differ in respect of PARP-1 protein expression,” Polish Journal of Pathology, vol. 63, no. 2, pp. 87–92, 2012. View at Google Scholar · View at Scopus
  31. M. Salemi, A. Galia, F. Fraggetta et al., “Poly (ADP-ribose) polymerase 1 protein expression in normal and neoplastic prostatic tissue,” European Journal of Histochemistry, vol. 57, no. 2, p. 13, 2013. View at Google Scholar · View at Scopus
  32. A. Galia, A. E. Calogero, R. Condorelli et al., “PARP-1 protein expression in glioblastoma multiforme,” European Journal of Histochemistry, vol. 56, no. 1, article e9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. J. V. Melo and D. J. Barnes, “Chronic myeloid leukaemia as a model of disease evolution in human cancer,” Nature Reviews Cancer, vol. 7, no. 6, pp. 441–453, 2007. View at Publisher · View at Google Scholar · View at Scopus